Major Study Reveals Hidden Side Effects of Popular GLP-1 Weight Loss Drugs
Analysis of 137,451 reports shows GLP-1 drugs linked to unexpected side effects beyond known gastrointestinal issues.
247 articles in this topic
Analysis of 137,451 reports shows GLP-1 drugs linked to unexpected side effects beyond known gastrointestinal issues.
HDM1002, an oral GLP-1 receptor agonist, achieved significant weight loss with manageable side effects in overweight Chinese adults.
Real-world weight loss significantly lowers cancer risk across multiple types, with benefits appearing within 3 years of BMI reduction.
New study reveals bariatric procedures are safe and effective for heart failure patients, reducing weight and medication needs.
New research shows visceral abdominal fat strongly predicts obesity-related cancer risk, independent of BMI or waist size.
Scientists discover how platelet-activating factor drives liver damage in obese women, revealing potential therapeutic targets.
New research reveals how obesity creates a cascade of cardiovascular and metabolic dysfunction that severely limits exercise capacity.
Major shift in diabetes mortality patterns reveals changing landscape of health risks and improved cardiovascular care.
New research calls for shifting diabetes treatment focus from heart health to preventing cognitive decline and dementia.
New analysis reveals significant gaps in school food policies across Europe, potentially impacting children's long-term health outcomes.
New research reveals how optimizing sleep patterns can significantly enhance metabolic function and glucose regulation.
New analysis reveals how large datasets in perinatal studies can create false causal conclusions about maternal and infant health.